Preferred Label : Tamsulosin;

MeSH definition : A sulfonamide derivative and adrenergic alpha-1 receptor antagonist that is used to relieve symptoms of urinary obstruction caused by BENIGN PROSTATIC HYPERPLASIA.;

MeSH hyponym : LY-253352; YM-617;

MeSH CAS label : 5-((2R)-2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxy-benzenesulfonamide;

MeSH Related Number : 106133-20-4 (Tamsulosin); 11SV1951MR;

Wikipedia link : https://en.wikipedia.org/wiki/Tamsulosin;

UNII : G3P28OML5I;

Details


Main resources

You can consult :

A sulfonamide derivative and adrenergic alpha-1 receptor antagonist that is used to relieve symptoms of urinary obstruction caused by BENIGN PROSTATIC HYPERPLASIA.

https://www.has-sante.fr/jcms/p_3476380/fr/vecalmys-succinate-de-solifenacine-/-chlorhydrate-de-tamsulosine-troubles-urologiques
2023
false
false
false
France
administration, oral
drug combinations
treatment outcome
insurance, health, reimbursement
tamsulosin and solifenacin
urinary incontinence, urge
Urinary Frequency
Enlarged Prostate with Lower Urinary Tract Symptoms
prostatic hyperplasia
urological agents
evaluation of the transparency committee
tamsulosin hydrochloride
Tamsulosin
Solifenacin Succinate

---
https://www.has-sante.fr/portail/jcms/c_2775796/fr/josir-mecir
https://www.has-sante.fr/portail/jcms/c_1278892/josir-mecir
https://www.has-sante.fr/portail/jcms/c_539602/fr/josir-mecir
2017
false
France
French
treatment outcome
Delayed-Action preparations
administration, oral
sulfonamides
tamsulosin
prostatic hyperplasia
insurance, health, reimbursement
adrenergic alpha-1 receptor antagonists
tamsulosin hydrochloride
evaluation of the transparency committee
Tamsulosin

---
http://www.has-sante.fr/portail/jcms/c_2741821/fr/combodart
http://www.has-sante.fr/portail/jcms/c_2741821/fr/combodart-dutasteride-tamsulosine-inhibiteur-de-la-5-reductase-alpha-bloquant
2016
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
drug combinations
administration, oral
adrenergic alpha-1 receptor antagonists
adrenergic alpha-1 receptor antagonists
5-alpha reductase inhibitors
5-alpha reductase inhibitors
Dutasteride
Dutasteride
tamsulosin and dutasteride
prostatic hyperplasia
tamsulosin hydrochloride
tamsulosin hydrochloride
treatment outcome
insurance, health, reimbursement
urinary retention
prostatic hypertrophy, benign
urological agents
urological agents
sulfonamides
sulfonamides
Tamsulosin
Tamsulosin

---
https://minerva-ebp.be/FR/Analysis/432
2016
false
false
false
Belgium
French
french abstract
scientific and technical information
treatment outcome
ureterolithiasis
nifedipine
sulfonamides
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68840153
2012
France
summary of product characteristics
package leaflet
tamsulosin
capsules
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68568244
2012
France
summary of product characteristics
package leaflet
tamsulosin
capsules
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68735615
2012
France
summary of product characteristics
package leaflet
tamsulosin
capsules
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68655083
2012
France
summary of product characteristics
package leaflet
capsules
tamsulosin
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69005124
2012
France
summary of product characteristics
package leaflet
capsules
tamsulosin
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63091974
2012
France
summary of product characteristics
package leaflet
capsules
tamsulosin
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65913639
2012
France
summary of product characteristics
package leaflet
dutasteride
tamsulosin
capsules
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61103520
2012
France
summary of product characteristics
package leaflet
tamsulosin hydrochloride
capsules
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66074097
2012
France
summary of product characteristics
package leaflet
capsules
tamsulosin
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60408088
2012
France
summary of product characteristics
package leaflet
tamsulosin
capsules
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65869609
2012
France
summary of product characteristics
package leaflet
tamsulosin
capsules
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60133973
2012
France
summary of product characteristics
package leaflet
capsules
france
tamsulosin
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68843466
2012
France
summary of product characteristics
package leaflet
tamsulosin
capsules
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65823679
2012
France
summary of product characteristics
package leaflet
capsules
tamsulosin
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69284407
2012
France
summary of product characteristics
package leaflet
tamsulosin
capsules
Tamsulosin

---
http://www.has-sante.fr/portail/jcms/c_1353463/avodart-dutasteride-chibro-proscar-finasteride-combodart-dutasteride-tamsulosine
http://www.has-sante.fr/portail/jcms/c_1353462/avodart-chibro-proscar-combodart-synthese-ct9291-9896-11612-12202
2012
false
France
French
Dutasteride
Dutasteride
administration, oral
insurance, health, reimbursement
dutasteride
tamsulosin and dutasteride
drug combinations
finasteride
finasteride
prostatic hyperplasia
finasteride
5-alpha reductase inhibitors
5-alpha reductase inhibitors
guidelines for drug use
sulfonamides
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67486011
2012
France
summary of product characteristics
package leaflet
capsules
tamsulosin
Tamsulosin

---
http://www.has-sante.fr/portail/jcms/c_1298559/combodart
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/combodart_05092012_avis_ct9291.pdf
2012
false
France
French
Dutasteride
Dutasteride
Tamsulosin
Tamsulosin
tamsulosin and dutasteride
administration, oral
adult
aged
drug combinations
insurance, health, reimbursement
prostatic hyperplasia
prostatic hyperplasia
sulfonamides
sulfonamides
urinary retention
treatment outcome
clinical trials, phase iii as topic
adrenergic alpha-1 receptor antagonists
adrenergic alpha-1 receptor antagonists
5-alpha reductase inhibitors
5-alpha reductase inhibitors
tamsulosin hydrochloride
tamsulosin hydrochloride
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_539618
http://www.has-sante.fr/portail/jcms/c_1281717/omix-omexel
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-08/omix_omexel_18072012_avis_ct12128.pdf
2012
France
French
administration, oral
Delayed-Action preparations
sulfonamides
insurance, health, reimbursement
tamsulosin
prostatic hyperplasia
adrenergic alpha-1 receptor antagonists
tamsulosin hydrochloride
treatment outcome
evaluation of the transparency committee
Tamsulosin

---
http://www.has-sante.fr/portail/display.jsp?id=c_400904
2006
France
evaluation of the transparency committee
tamsulosin hydrochloride
Tamsulosin

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2005/14327a-fra.php
2005
Canada
French
English
adrenergic alpha-antagonists
sulfonamides
iris diseases
cataract extraction
intraoperative complications
sulfonamides
adrenergic alpha-1 receptor antagonists
pharmacovigilance note
Intraoperative floppy iris syndrome
Tamsulosin

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.